A large body of research has shown the presence of a complex pathway of communications between the gut and the brain. It is now recognized that, through this pathway, the microbiota can influence brain homeostasis and plasticity under normal and pathological conditions. This review aims at providing an overview of preclinical and clinical pieces of evidence supporting the possible role of gutbrain axis modulation in physiological aging, in a neurodevelopmental disorder, the autism spectrum disorders and in a substance abuse disorder, the alcohol addiction. Since the normalization of gut flora can prevent changes in the behavior, we postulate that the gut-brain axis might represent a possible target for pharmacological and dietary strategies aimed at improving not only intestinal but also mental health. The present review also reports some regulatory considerations regarding the use of probiotics, illustrating the most debated issues about the possibility of considering probiotics not only as a food supplement but also as a "full" medicinal product.

Petrella, C., Farioli-Vecchioli, S., Cisale, G.y., Strimpakos, G., Borg, J.j., Ceccanti, M., et al. (2020). A healthy gut for a healthy brain: preclinical, clinical and regulatory aspects. CURRENT NEUROPHARMACOLOGY [10.2174/1570159X18666200730111528].

A healthy gut for a healthy brain: preclinical, clinical and regulatory aspects

Nisticò, Robert
2020-07-30

Abstract

A large body of research has shown the presence of a complex pathway of communications between the gut and the brain. It is now recognized that, through this pathway, the microbiota can influence brain homeostasis and plasticity under normal and pathological conditions. This review aims at providing an overview of preclinical and clinical pieces of evidence supporting the possible role of gutbrain axis modulation in physiological aging, in a neurodevelopmental disorder, the autism spectrum disorders and in a substance abuse disorder, the alcohol addiction. Since the normalization of gut flora can prevent changes in the behavior, we postulate that the gut-brain axis might represent a possible target for pharmacological and dietary strategies aimed at improving not only intestinal but also mental health. The present review also reports some regulatory considerations regarding the use of probiotics, illustrating the most debated issues about the possibility of considering probiotics not only as a food supplement but also as a "full" medicinal product.
30-lug-2020
Online ahead of print
Rilevanza internazionale
Articolo
Esperti anonimi
Settore BIO/14 - FARMACOLOGIA
English
aging
alcohol
autism
brain disorders
gut-brain axis
preclinical and clinical studies
regulatory aspects
Petrella, C., Farioli-Vecchioli, S., Cisale, G.y., Strimpakos, G., Borg, J.j., Ceccanti, M., et al. (2020). A healthy gut for a healthy brain: preclinical, clinical and regulatory aspects. CURRENT NEUROPHARMACOLOGY [10.2174/1570159X18666200730111528].
Petrella, C; Farioli-Vecchioli, S; Cisale, Gy; Strimpakos, G; Borg, Jj; Ceccanti, M; Fiore, M; Monteleone, G; Nisticò, R
Articolo su rivista
File in questo prodotto:
File Dimensione Formato  
CN-2020-0149.R revised.pdf

solo utenti autorizzati

Descrizione: A Healthy Gut for a Healthy Brain: Preclinical, Clinical and Regulatory Aspects
Tipologia: Documento in Pre-print
Licenza: Copyright dell'editore
Dimensione 503.76 kB
Formato Adobe PDF
503.76 kB Adobe PDF   Visualizza/Apri   Richiedi una copia

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2108/259636
Citazioni
  • ???jsp.display-item.citation.pmc??? 6
  • Scopus 20
  • ???jsp.display-item.citation.isi??? 17
social impact